Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom. [electronic resource] by
- Hernandez Alava, Monica
- Wailoo, Allan
- Grimm, Sabine
- Pudney, Stephen
- Gomes, Manuel
- Sadique, Zia
- Meads, David
- O'Dwyer, John
- Barton, Garry
- Irvine, Lisa
Producer: 20180423
In:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 21
Availability: No items available.
|
|
17.
|
Corrigendum: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. [electronic resource] by
- Stevenson, Matt
- Archer, Rachel
- Tosh, Jon
- Simpson, Emma
- Everson-Hock, Emma
- Stevens, John
- Hernandez-Alava, Monica
- Paisley, Suzy
- Dickinson, Kath
- Scott, David
- Young, Adam
- Wailoo, Allan
Publication details: Health technology assessment (Winchester, England) 11 2016
In:
Health technology assessment (Winchester, England) vol. 20
Availability: No items available.
|
|
18.
|
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. [electronic resource] by
- Stevenson, Matt
- Archer, Rachel
- Tosh, Jon
- Simpson, Emma
- Everson-Hock, Emma
- Stevens, John
- Hernandez-Alava, Monica
- Paisley, Suzy
- Dickinson, Kath
- Scott, David
- Young, Adam
- Wailoo, Allan
Producer: 20180312
In:
Health technology assessment (Winchester, England) vol. 20
Availability: No items available.
|
|
19.
|
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. [electronic resource] by
- Longworth, Louise
- Yang, Yaling
- Young, Tracey
- Mulhern, Brendan
- Hernández Alava, Mónica
- Mukuria, Clara
- Rowen, Donna
- Tosh, Jonathan
- Tsuchiya, Aki
- Evans, Pippa
- Devianee Keetharuth, Anju
- Brazier, John
Producer: 20141020
In:
Health technology assessment (Winchester, England) vol. 18
Availability: No items available.
|
|
20.
|
The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate. [electronic resource] by
- Stevenson, Matt D
- Wailoo, Allan J
- Tosh, Jonathan C
- Hernandez-Alava, Monica
- Gibson, Laura A
- Stevens, John W
- Archer, Rachel J
- Simpson, Emma L
- Hock, Emma S
- Young, Adam
- Scott, David L
Producer: 20180423
In:
The Journal of rheumatology vol. 44
Availability: No items available.
|